Compare ATRC & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | ICHR |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 605.5M |
| IPO Year | 2005 | 2016 |
| Metric | ATRC | ICHR |
|---|---|---|
| Price | $39.22 | $20.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $52.22 | $26.50 |
| AVG Volume (30 Days) | 450.9K | ★ 521.3K |
| Earning Date | 02-11-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $518,304,999.00 | ★ $957,337,000.00 |
| Revenue This Year | $16.90 | $13.48 |
| Revenue Next Year | $12.25 | $5.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 15.80 | ★ 16.86 |
| 52 Week Low | $28.29 | $13.12 |
| 52 Week High | $43.11 | $35.56 |
| Indicator | ATRC | ICHR |
|---|---|---|
| Relative Strength Index (RSI) | 50.78 | 67.23 |
| Support Level | $40.11 | $18.35 |
| Resistance Level | $41.33 | $19.37 |
| Average True Range (ATR) | 1.10 | 0.75 |
| MACD | -0.37 | 0.22 |
| Stochastic Oscillator | 16.07 | 97.96 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.